DOES IMMUNOSUPPRESSIVE TREATMENT AMELIORATE MORPHOLOGY CHANGES IN ENCAPSULATING PERITONEAL SCLEROSIS?


Bozkurt D. , SIPAHI S., CETIN P., HUR E., OZDEMIR O., ERTILAV M., ...Daha Fazla

PERITONEAL DIALYSIS INTERNATIONAL, cilt.29, 2009 (SCI İndekslerine Giren Dergi) identifier identifier identifier

  • Cilt numarası: 29
  • Basım Tarihi: 2009
  • Dergi Adı: PERITONEAL DIALYSIS INTERNATIONAL

Özet

Encapsulating peritoneal sclerosis (EPS) is a clinical syndrome associated with ileus symptoms and irreversible sclerosis of the peritoneal membrane. Inflammation, fibrosis, and neoangiogenesis are the main features of the pathophysiology. No evidence-based therapy is currently available for EPS. In recent years, anti-inflammatory and immunosuppressive (IS) treatment modalities have become more popular.